Oral hygiene products.
Abstract
Oral hygiene products comprising of a calcium ion source, a fluoride ion source, and a calcium sequestering agent, having specific binding and solubility characteristics, provide effective anticaries protection.

Term
Term ended
Projected expiry passed 28 February 2003, 23.6 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
9 claims: 4 independent, 5 dependent
- 1An oral hygiene product providing anticaries protection to the teeth characterized by:(A) a calcium ion source capable of providing in use at least 0.015% soluble calcium as defined in (B) below;(B) a calcium sequestering agent or mixture of calcium sequestering agents effective in controlling the rate of precipitation of CaF 2 , said sequestering agent being one that does not reduce the total soluble calcium, said total soluble calcium comprising both ionic calcium and calcium complexed by the sequestering agent, below 0.015%, and being one with an effective stability constant (K ) ranging from 10 2.8 to 10 6 1/mole, as defined by the followng equation: wherein [Ca] is the total molar concentration of uncomplexed calcium ion, [A] is the total molar . concentration of soluble sequestering agent uncomplexed by any metal ions, and [CaA] is the total molar concentration of soluble sequestering agent complexed by calcium;and (C) a fluoride ion source capable of providing in use from 0.0015% to 0.5% fluoride, wherein said product has a pH of from 4.5 to 8.8 at 25°C - 37°C if an aqueous solution or when diluted with salivary secretions.
- 2An oral hygiene product according to Claim 1, characterized in that the calcium sequestering agent or mixture of calcium sequestering agents has an effective stability constant (K ) ranging from 10 3.3 to 105.3 1/mole.
- 4An oral hygiene product according to Claim 3, characterized in that the calcium sequestering agent(s) is selected from N-(2-hydroxyethyl)-iminodiacetic acid, nitrilotriacetic acid, N-(2-carboxyethyl)-iminodiacetic acid, DL-2-methylnitrilotriacetic acid, N-(phosphonomethyl)-iminodiacetic acid, N-(2-sulfoethyl)-iminodiacetic acid, DL-N-(2-hydroxyethyl)-2-methyliminodiacetic acid, N-(2-methoxyethyl)-iminodiacetic acid, N-(2-oxopropyl)-iminodiacetic acid, N-acetamidoiminodiacetic acid, N-hydroxyethylethylenediaminetriacetic acid, 2-aminobenzoic-N,N-diacetic acid, N,N-bis-(2-hydroxyethyl)-ethylenedinitrilo-N', N'-diacetic acid, citric acid, sodium potassium, and calcium salts of these sequestering agents, and mixtures .thereof.
- 5An oral hygiene product according to Claim 4, characterized in that the calcium ion source is selected from calcium hydroxide, calcium chloride, calcium acetate, calcium formate, calcium lactate, calcium nitrate, calcium gluconate, calcium glycerophosphate, calcium benzoate, calcium isobutyrate, calcium propionate, calcium salicylate, the calcium salts of the sequestering agents, and mixtures thereof.
- 6An oral hygiene product according to any of claims 1 to 5 characterized in that the fluoride ion source is capable of providing from 0.02% to 0.10% fluoride ion and is selected from sodium fluoride, stannous fluoride, potassium fluoride, zinc fluoride, betaine fluoride, alanine stannous fluoride, sodium fluorosilicate, hexylamine fluoride, sodium monofluorophosphate, and mixtures thereof.
- 8An oral hygiene product according to any of Claims 1 to 6 characterized in that said product is in the form of two compositions wherein one composition contains the calcium sequestering agent and the calcium ion source and the other composition contains the fluoride ion source, both compositions have a pH of from 4.5 to 8.8 if aqueous solutions or when diluted with salivary excretions.
- 9An oral hygiene product according to Claim 8 characterized by a delivery system providing for physical separation of the two compositions and for simultaneous or sequential application thereof to teeth.
Independent claims9
43 paragraphs in 5 sections, as filed
0001This invention relates to oral hygiene products providing. anticaries protection to teeth. The products comprise a calcium ion source, a fluoride ion source and a calcium sequestering agent having specific binding and solubility characteristics to control the precipitation of CaF<sub>2</sub>.
0002There are several mechanisms through which fluoride is thought to exert its anticaries effect. One possible mechanism involves fluoride's antimicrobial effects on oral bacteria. One antimicrobial effect seems to center around a reduction in the acidic production of plaque. Another antimicrobial effect may center around fluoride's inhibition of polysaccharide synthesis, thereby causing an alteration of plaque composition.
0003The second mechanism suggested by which fluoride could be providing anticaries protection is in its interaction with tooth enamel. Fluoride and hydroxyapatite (HA) (major enamel component) form fluoroapatite (FA). When increased quantities of fluoride are available, it is postulated that the concentration of FA increases and the solubility of the original enamel is decreased - (FA being less soluble than HA).
0004A third mechanism involves fluoride's ability, when retained in the oral environment following treatment, to accelerate the material remineralization of tooth enamel.
0005The prior art has addressed several ways in which to provide more fluoride to tooth enamel. For instance, topical high fluoride ion. concentration treatments are provided by dentists. This requires a visit to the dentist and therefore methods and products for easier fluoride treatment to teeth have been and continue to be sought.
0006US-A-2,627,493 (Frederick G. Merckel, Jan. 18, 1955) teaches the use of a chewing gum which delivers fluoride to the teeth. US-A- 4,080,440 (David N. DiGiulio and R. J. Grabenstetter, March 21, 1978) typifies the use of a two-part rernineralization product that delivers a fluoride source, a phosphate source and a calcium source to enamel. Another two-part product, such as that disclosed in <sup>US-</sup>A- 4,108,980 (Edward John Duff, August 22, 1978), involves the sequential applicatien of a fluoride source followed by a calcium source. <sub>US</sub>-A-4,19<sub>3</sub>,<sub>9</sub>88 (Geoffrey C. Forward, et al, March 18, 1980) utilizes a two-part dentifrice (stripes of gel and toothpaste) to provide calcium ion and fluoride ion sources. However, none of the above references provide separate calcium and fluoride ion sources that allow for controlled CaF<sub>2</sub> precipitation. Prevention of precipitation is shown in <sub>U</sub>S-A- 4,177,258 (Maria C. S. ε Abdul Gaffar, December 4, 1979) and <sub>US</sub>-A-4,183,915 (Maria C. S. and Abdul Gaffar, January 15, 1980).
0007J. D. B. Featherstone, et al, Caries Research 15: 221-235 (1981) discloses compositions that may provide controlled precipitation of CaF<sub>2</sub> but not in the amounts contemplated herein and with fluoride levels below the limits of this invention.
0008References which disclose possible roles for CaF<sub>2</sub> in caries prevention are Marion D. Francis, et al, Adv. in Oral Biology 3: 83 - 120 (1968); H. G. McCann, Arch. Oral Biol. 13: 987 - 1001 (1968); Zao-Shon Liang and William 1. Higuchi, J. Phys. Chem. 77: 1704 - 1710 (1973); V. Calavaska, et al, Arch. Oral Biol. 20: 333-339 (1975); M. Joost Larsen, et al, Scand. - Biol. 20: 327-333 (1977); S. Duke and G. C. Forward, Caries Res. 12: 12-20 (1978); M. Joest Larsen and O. Fejerskov, Scand. J. Dent. Res. 86: 337-345(1978); O. Fejerskov, et al, Acta Odont. Scand. 39: <ul id="ul0001" list-style="none"><li>241-249 (1981); S. Chandler, et al, J. Dent. Res. 61: 403-407 (1982). All of the above references are incorporated herein by reference.</li></ul>
0009The invention described herein provides anticaries protection via delivery of a controlled supersaturated CaF<sub>2</sub> solution to tooth enamel. A soluble calcium ion source, a calcium sequestering agent possessing specific solubility and binding properties and a soluble fluoride ion source are used in the present compositions. One execution of the present invention involves. having all components present in a single composition. Other executions involve the use of the calcium ion source and the calcium sequestering agent in one composition and the fluoride ion source in another. When the composition(s) is used, it is desired to buffer the free calcium ion concentration such that an aqueous mixture with fluoride is near the critical supersaturation level for CaF<sub>2</sub>. This will allow for maximum deposition of CaF<sub>2</sub>. Beiow the critical level all of the components can be present together in a single aqueous composition (a metastable solution) while above the critical level two separate compositions are preferred. The essential as well as optional components are described in detail below.
0010The present invention provides anticaries protection by delivering controlled amounts of CaF 2 to tooth enamel. The invention uses a calcium-sequestering agent with a stability constant sufficient to inhibit uncontrolled and exceedingly rapid precipitation of CaF<sub>2</sub>.
Calcium Ion Source
0011Calcium ion sources which can be used in the present invention are those sources safe for use in the oral cavity capable of providing at least about 0.015% total soluble calcium in ionic form and as soluble complexes of the sequestering agent when the product is used in the mouth. This is also the concentration in a single aqueous rinse composition product wherein all of the components are present. If the calcium ion source is present along with the sequestering agent in one aqueous rinse composition and the fluoride ion source is present in another, the amount of soluble calcium present when the two are mixed should be at least the 0.015%. Similarly in a dentifrice or other nonrinse product the concentration of soluble calcium when diluted in the mouth (generally a dilution of 1 part dentifrice to 3 parts saliva and water) is at least 0.015%. Using these data, the skilled artisan can easily make products having the proper concentration of components. If the composition(s) is an aqueous solution, and when diluted if it is not, it should have a pH from about 4.5 to .about 8.8, preferably from about 6.5 to about 7.8. Preferably, calcium ion sources providing more than 5% total ionic and soluble complexed calcium in the mouth will not be used, and most preferred calcium ion sources should provide from about 0.04% to about 0.25% total soluble calcium in ionic and soluble complexed form. Representative sources include calcium hydroxide, calcium chloride, calciun acetate, calcium formate, calcium lactate, calcium nitrate, calcium gluconate, calcium glycerophosphate, calcium benzoate, calcium isobutyrate, calcium propionate, calcium salicylate, and mixtures thereof. Other suitable calcium ion sources include the calcium salts of the sequestering agents previously described.
0012The preferred calcium ion sources include the calcium salts of the sequestering agents, calcium hydroxide, calcium chloride, and mixtures thereof.
Calcium Sequestering Agents
0013Calcium sequestering agents with suitable stability constants, K , as defined by the following formula, are used to buffer the calcium ion concentration when the composition is used at levels such that the ion product of [Ca] [F]<sup>2</sup> is ≥ <sub>2 x</sub> 10<sup>-9</sup> M<sup>3</sup>, or mole<sup>3</sup>/liter<sup>3</sup>.<maths id="math0001"><img file="EP0089136A2_D0001.tif" /></maths>
0014(In the above equation, [CaA] is the total molar concentration of the calcium complexed agent, [A] is the total molar concentration of sequestering agent not complexed by metal ion, and [Ca] represents the total molar concentration of uncomplexed calcium ion.
0015It is seen that the ion product value, [Ca] [F]<sup>2</sup>, is also dependent on the free fluoride ion concentration. Therefore, the appropriate sequestering agent for use in such a product will depend on this fluoride concentration. It has been found that agents with effective stability constants ranging from 10<sup>2.8</sup> to 10<sup>6</sup> I/mole, preferably from about 10<sup>3.3</sup> to about 105.3 I/mole, provide the appropriate binding properties for calcium while maintaining appropriate levels of free fluoride ions.
0016Such agents must also be ones which do not reduce the total soluble calcium in ionic form and complexed form below 0.015% in the mouth. This is in order to provide enough calcium to react to form CaF<sub>2</sub>. Sequestering agents present at molar concentrations from about 0.01 to about 0.10, provide optimal levels of calcium for calcium fluoride formation.
0017Examples of sequestering agents suitable for use in the present invention include N-(2-hydroxy-ethyl-iminodiacetic acid (supplied by Aldrich Chemical Company), nitrilotriacetic acid (supplied by Aldrich Chemical Company), N-(2-carboxyethyl)-iminodiacetic acid, DL-2-methylnitrilotriacetic acid, N-(phosphonomethyl)-iminodiacetic acid, N-(2-sulfoethyl)-iminodiacetic acid, DL-N-(2-hydroxyethyl)-2-methyl-iminodiacetic acid, N-(2-methoxyethyl)-iminodiacetic acid, N-(2-oxopropyl)-iminodiocetic acid, N-acetamidoiminodiacetic acid (supplied by Aldrich Chemical Company), N-hydroxyethylethylenediaroinetriacetic acid (supplied - by Aldrich Chemical Company), 2-aminobenzoic-N,N-diacetic acid, N,N-bis-(2-hydroxyethyl)-ethyfenedinitrilo-N', N'diacetic acid, citric acid and mixtures thereof (supplied by Aldrich Chemical Company), or suitable salts thereof; for example, sodium, potassium, and calcium (Taken from Critical Stability Constants, A. E. Mortell and R.. Smith (Plenum Press: New York ) 1974 incorporated herein by reference.) Preferred sequestering agents are N-(2-hydroxycthyl-) iminodiacetic acid, N-hydroxycthyl- ethylenediaminetriacetic acid, N-acetaminodiscetic acid, nitrilotriacetic acid and mixtures thereof.
Fluoride lor, Source
0018The present invention includes a fluoride ion source such that from about 0.0015% to about 0.5%, preferably from about 0.02% to about 0.10%, fluoride ion is provided when the product is used. The statements made earlier about the calcium ion concentration in the product composition(s) are also applicable to the fluoride ion source. Suitable fluoride sources include sodium fluoride, stannous fluoride, potassium fluoride, zinc fluoride, betaine fluoride, alanine stannous fluoride, sodium flucrosilicate, hexylamine fluoride, sodium monofluorophosphate and mixtures thereof. A preferred fluoride ion source is sodium fluoride. The fluoride that would be provided by sodium monofluorophosphate results from the hydrolysis monofluorophosphate undergoes to form fluoride and phosphate ions in aqueous solutions.
0019In order to provide the most effective anticaries benefit (minimal interference with fluoride deposition), phosphate ion levels should not exceed 0.06%, as the orthophosphate ion, when the present composition(s) is used.
0020When the present compositions providing enhanced anticaries protection are delivered to the teeth, at least 0.002 gram calcium ion, preferably from about 0.006 to about 0.030 gram calcium ion, should be provided by the calcium sequestering agent and calcium ion source component, while the amount of fluoride ion provided should be at least 0.0001 gram, preferably from about 0.003 to about 0.015 gram fluoride.
0021Examples of delivery systems utilizing two separate composi- . tions in which the calcium ion source and sequestering agent are present in one composition and the fluoride ion source in another include the following: mouthwash-mouthwash; toothpaste- toothpaste; toothpaste-mouthwash: mouthwash-toothpaste; beverage-beverage; candy drop-candy drop; toothpowder- toothpowder; and so forth. While the above systems provide for physical separation of the compositions, the compositions may be used either simultaneously or sequentially, preferably simultaneously, i.e. a portion of the two mouthwashes mixed together just prior to use; a strip of each of the two toothpastes put onto a single brush; and so forth.
0022Other examples of systems which provide physical separation of the calcium ion materials and fluoride ions include, but are not limited to, a toothpaste in. which one component is encapsulated for delayed release; a two-compartment bottle; a lozenge with a laminated structure; a laminated chewing gum; and so forth.
0023In addition to the systems described above wherein physical separation is provided, single compositions providing no separation may be used and discussed previously. Such a composition is a single phase mouthwash.
0024Suitable toothpastes can be made by using a 0.5% to 50%, preferably 5% to 35%, of an abrasive. Other ingredients include from about 0.2% to about 7% of a sudsing agent, from about 0.1% to about 5% of a binding agent, from 0% to about 50% of a humectant, with water and minors making up the balance.
0025Abrasives useful in the toothpastes include silica xerogels such as those disclosed in U.S. Patent 3,538,230, November 3, 1970, to Pader et al., incorporated herein by reference. Other toothpaste abrasives which can be used in the present invention are beta-phase calcium pyrophosphate, zirconium silicate, and thermosetting polymerized resins as described by Cooley et al. in U.S. Patent No. 3,070,510, December 25, 1962, incorporated herein by reference. In addition, precipitated silicas and insoluble metaphosphates can be used. Mixtures of abrasives are permitted with silica xerogels and precipitated silicas being preferred.
0026Suitable sudsing agents are preferably non-soap anionic or nonionic synthetic detergents. Water-soluble salts of alkyl sulfates having from about 10 to about 18 carbon atoms in the alkyl radical such as sodium lauryl sulfate are suitable. Other types of sudsing agents useful in this invention are water-soluble salts of sulfonated monoglycerides of fatty acids having from about 10 to about 18 carbon atoms of which sodium monoglyceride sulfonate is an example. Salts of C<sub>10</sub> - C<sub>18</sub> fatty acid amides of taurine are acceptable for use. Both sodium N-methyt-N-palmitoyl tauride and sodium N-coconut-acid-N-methyl taurate typify this category. Salts of C<sub>10</sub> - C<sub>18</sub> fatty acid esters of isethionic acid, and substantially saturated aliphatic acyl amides of saturated monoaminocarboxylic acids having 2 to 6 carbon atoms, and in which the acyl radical contains 12 to 16 carbon atoms are useful also. Sodium-N-lauryl sarcoside is an example of the latter.
0027A binding material is also useful in the present toothpaste compositions. One function the material serves is to thicken the product, while another function is to provide a desirable consistency for the toothpaste. Such ingredients include water-soluble salts of cellulose ethers such as sodium carboxymethyl cellulose, hydroxypropyl cellulose, and hydroxyethyl cellulose. Other thickeners which can be used are the natural gums which include gum karaya, gum arabic and gum tragacanth. Carboxyvinyl polymers (e.g. Carbopols® - B. F. Goodrich Co.) are also useful.
0028A humectant is desirably used to keep the toothpaste from hardening. Suitable humectants include glycerin, sorbitol, propylene glycol, and other edible polyhydric alcohols.
0029Flavoring agents are also useful in toothpastes. These flavoring agents include oil of wintergreen, oil of peppermint, oil ' of spearmint, oil of sassafras, and oil of close among many others. Along with a flavoring substance, sweeteners such as saccharin, dextrose, levulose, 6 methyloxathiazinone and sodium cyclamate can be used.
0030Additionally, cationic antimicrobial agents (e.g. bisbiguan- ides and quaternary ammonium compounds) such as those disclosed in U.S. Patent 4,183,916, January 15, 1980 to Rodon (incorporated herein by reference) may also be used in the present compositions. These agents preferably would be present in the fluoride composition if two compositions are employed.
0031The following examples, which are intended merely to illustrate the present invention and not be limiting thereof, set forth several types of suitable product forms. All percentages and ratios herein are by weight unless otherwise specified.
0032The following are two toothpastes representative of the present invention:
EXAMPLE 1
0033<tables id="tabl0001" num="0001"><img file="EP0089136A2_D0002.tif" /></tables><tables id="tabl0002" num="0002"><img file="EP0089136A2_D0003.tif" /></tables>
0034Another embodiment of the present invention is a two-part mouthwash. Mouthwashes typically contain from about 3% to about 60%, preferably 5% to 30%, ethyl alcohol. The alcohol acts as an antibacterial agent and as a solubilizer of other additives. Other components include from about 30% to about 90% water, from about 5% to about 20% of a humectant such as glycerin, from about 0.01% to about 0.1% antibacterial agent, from about 0.01% to about 0.5% sweetener, about 0.01% flavoring agent, and from about 0.1% to about 1% emulsifier such as polyoxyethylene (20) sorbitan mono-oleate. Those familiar with the art will recognize several flavoring agents and sweetening agents capable for use in a mouthwash product.
EXAMPLE II
0035Two separate mouthwashes for use in accordance with the present invention are made of the following ingredients: <tables id="tabl0003" num="0003"><img file="EP0089136A2_D0004.tif" /></tables><tables id="tabl0004" num="0004"><img file="EP0089136A2_D0005.tif" /></tables>
EXAMPLE III
0036A suitable single mouthwash for use in accordance with the present invention can be made in which a meaningful increase of fluoride uptake by tooth enamel is possible. <tables id="tabl0005" num="0005"><img file="EP0089136A2_D0006.tif" /></tables>
0037In addition to the above-discussed embodiments, the present invention can be practiced by using a calcium-containing toothpaste followed by a fluoride containing mouthrinse. The following example is such a suitable system for use in accordance with the present invention:
EXAMPLE IV
0038<tables id="tabl0006" num="0006"><img file="EP0089136A2_D0007.tif" /></tables><tables id="tabl0007" num="0007"><img file="EP0089136A2_D0008.tif" /></tables>
0039Another form of the present invention is as a chewing gum. Those familiar with the art will recognize that a gum base, humectant, sweeteners and flavors are the major ingredients of a gum. The following example is a chewing gum utilizing the essential components of the present invention:
EXAMPLE V
0040<tables id="tabl0008" num="0008"><img file="EP0089136A2_D0009.tif" /></tables><tables id="tabl0009" num="0009"><img file="EP0089136A2_D0010.tif" /></tables>
Contents5
11 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| EP0783034A2 | Cited by | European Patent Office (EPO) | Search report |
| US5476647A | Cited by | United States of America | Search report |
| EP0520457A2 | Cited by | European Patent Office (EPO) | Search report |
| GB2239601A | Cited by | United Kingdom | Search report |
| US6451757B2 | Cited by | United States of America | Applicant |
| US6190642B1 | Cited by | United States of America | Applicant |
| EP0783034A3 | Cited by | European Patent Office (EPO) | Search report |
| GB2292886B | Cited by | United Kingdom | Search report |
| EP0520457A3 | Cited by | European Patent Office (EPO) | Search report |
| WO2006058933A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US6008176A | Cited by | United States of America | Search report |
| US5723107A | Cited by | United States of America | Search report |
| US5045305A | Cited by | United States of America | Search report |
| EP1011621A1 | Cited by | European Patent Office (EPO) | Examiner |
| DE4041946A1 | Cited by | Germany | Search report |
| US5786313A | Cited by | United States of America | Search report |
| WO9620693A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| GB2239601B | Cited by | United Kingdom | Search report |
| US6221834B1 | Cited by | United States of America | Applicant |
| FR2834635A1 | Cited by | France | Search report |
| US6005141A | Cited by | United States of America | Search report |
| AU704632B2 | Cited by | Australia | Search report |
| US5891448A | Cited by | United States of America | Search report |
| WO03059314A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US5531983A | Cited by | United States of America | Search report |
| EP1011621B1 | Cited by | European Patent Office (EPO) | Examiner |
| WO03059314A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US8591867B2 | Cited by | United States of America | Applicant |
| US5487906A | Cited by | United States of America | Search report |
| WO9716160A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US4997587A | Cited by | United States of America | Search report |
| WO9204006A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| WO9507685A1 | Cited by | World Intellectual Property Organization (WIPO) | International search |
| US7737179B2 | Cited by | United States of America | Applicant |
| US6426229B1 | Cited by | United States of America | Applicant |
| GB2292886A | Cited by | United Kingdom | Search report |
| FR2834635A1 | Cited by | France | Search report |
| EP0040738A2 | Cites | European Patent Office (EPO) | Search report |
| FR1186136A | Cites | France | Search report |
| US2191199A | Cites | United States of America | Search report |
| FR2305965A1 | Cites | France | Search report |
| FR2361851A1 | Cites | France | Search report |
| US3558769A | Cites | United States of America | Search report |
| US3699221A | Cites | United States of America | Search report |
| US4177258A | Cites | United States of America | Search report |
| US4183915A | Cites | United States of America | Search report |
| US4357318A | Cites | United States of America | Search report |
6 members in 5 offices; this record represents the family
Priority claims10
| Document | Office | Kind | Date |
|---|---|---|---|
| 356678 | United States of America | – | |
| 35667882 | United States of America | A | |
| 35667882 | United States of America | A | |
| 463378 | United States of America | – | |
| 46337883 | United States of America | A | |
| 46337883 | United States of America | A | |
| 356678 | – | – | – |
| 463378 | – | – | – |
| US19820356678 | – | – | – |
| US19830463378 | – | – | – |
Members6
| Document | Office | Kind | |
|---|---|---|---|
| FI830786A0 | Finland | A0 | |
| AU1219983A | Australia | A | |
| EP0089136A2This record | European Patent Office (EPO) | A2 | |
| JPS58219107A | Japan | A | |
| EP0089136A3 | European Patent Office (EPO) | A3 | |
| GR77131B | Greece | B |
8 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Application withdrawnWithdrawn18W | 18W | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN WITHDRAWNSTAA | STAA | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | |
| Designated contracting statesAK | AK | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 0089136
- Publication, DOCDB
- 0089136
- Publication, EPODOC
- EP0089136
- Application
- 83301050
- Application, DOCDB
- 83301050
- Application, EPODOC
- EP19830301050
Titles3
- German
- Orale Hygieneprodukte
- English
- Oral hygiene products
- French
- Produits d'hygiène orale
Classification
- CPC, 6
- A61K8/19
- A61K8/21
- A61K8/44
- A61K2800/51
- A61K2800/88
- A61Q11/00
- IPC, 4
- A61K8 19
- A61K8 21
- A61K8 44
- A61Q11 00
Designated states1
- Contracting states, 1
- Sweden